1h Free Analyst Time
The single cell analysis market is forecasted to grow by USD 4.62 billion during 2024-2029, accelerating at a CAGR of 18.2% during the forecast period. The report on the single cell analysis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer, growing research and development in pharmaceutical and biotechnology industries, and growth in stem cell research.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The single cell analysis market is segmented as below:
By Product
- Consumables
- Instrument
By Type
- Human cells
- Animal cells
By Technique
- Flow cytometry
- Next-generation sequencing (NGS)
- Polymerase chain reaction (PCR)
- Microscopy
- Mass spectrometry
By Application
- Research
- Medical
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the single cell analysis market covers the following areas:
- Single Cell Analysis Market sizing
- Single Cell Analysis Market forecast
- Single Cell Analysis Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by Type
10 Market Segmentation by Technique
11 Market Segmentation by Application
12 Customer Landscape
13 Geographic Landscape
14 Drivers, Challenges, and Opportunity/Restraints
15 Competitive Landscape
16 Competitive Analysis
17 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global single cell analysis market: 10X Genomics Inc., Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., CellChorus Inc., Danaher Corp., DiaSorin SpA, Fluidigm Corp., Illumina Inc., Merck KGaA, NanoString Technologies Inc., QIAGEN N.V., RareCyte Inc, Sartorius AG, Takara Holdings Inc., Thermo Fisher Scientific Inc., and Yokogawa Electric Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising incidence of chronic diseases and genetic disorders."
According to the report, one of the major drivers for this market is the increasing prevalence of cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 10X Genomics Inc.
- Agilent Technologies Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- CellChorus Inc.
- Danaher Corp.
- DiaSorin SpA
- Fluidigm Corp.
- Illumina Inc.
- Merck KGaA
- NanoString Technologies Inc.
- QIAGEN N.V.
- RareCyte Inc
- Sartorius AG
- Takara Holdings Inc.
- Thermo Fisher Scientific Inc.
- Yokogawa Electric Corp.
